Initial tumor size predicts histologic response and survival in localized osteosarcoma patients

Abstract

The initial tumor size is closely related to histologic response and is an important prognostic factor in osteosarcoma. Tumor size is best represented by AJCC stage and RTP. These parameters may serve as a basis for risk-adapted therapy in combined stratification with histologic response.

References

Page 1

	Year	Citations
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Stefan Bielack Journal of Clinical Oncology Prognostic FactorsExtremity OsteosarcomasSurgical OncologyMedicineCancer Management	2002	1.9K
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Stefan Bielack, Beate Kempf‐Bielack, G. Delling, Journal of Clinical Oncology	2002	1.8K
Neoadjuvant chemotherapy for high‐grade central osteosarcoma of the extremity Gaetano Bacci, Franco Bertoni, Alessandra Longhi, Cancer	2003	251
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin G. Bacci, Piero Picci, Pietro Ruggieri, Cancer Surgical OncologyMedicineCancer ManagementMetronomic TherapySurgery	1990	235
Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute Stefano Ferrari, Francesco Bertoni, M. Mercuri, Annals of Oncology Surgical OncologyPredictive FactorsMedicineCancer ManagementSpinal Oncology	2001	170
Expression Profiles of Osteosarcoma That Can Predict Response to Chemotherapy Tsz‐Kwong Man, Murali Chintagumpala, Jaya Visvanathan, Cancer Research Surgical OncologyPrognosisPathologyPredictor GenesCancer Biology	2005	138
A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J H Edmonson, S J Green, J C Ivins, Journal of Clinical Oncology Surgical OncologyPostsurgical Adjuvant TreatmentPrimary Adjuvant ChemotherapySurgeryPharmacotherapy	1984	106
Value of P-Glycoprotein and Clinicopathologic Factors as the Basis for New Treatment Strategies in High-Grade Osteosarcoma of the Extremities Massimo Serra, Katia Scotlandi, Gemma Reverter‐Branchat, Journal of Clinical Oncology	2003	103
Increased survival, limb preservation, and prognostic factors for osteosarcoma Antônio Sérgio Petrilli, F Gentil, Sidnei Epelman, Cancer Surgical OncologyNonmetastatic OsteosarcomaMedicineSurgical PathologyTumor Necrosis	1991	94
MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study Jay S. Wunder, Shelley B. Bull, Vicky Aneliunas, Journal of Clinical Oncology	2000	92

Page 1